Pharmacare Premium Ltd. Remedica Ltd

Poland

All drugs from this manufacturer

  • SUNITINIB MYLAN

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive, unresectable pancreatic neuroendocrine tumors (pNET).

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 12.5 mg

    ATC: L01EX01

  • SUNITINIB MYLAN

    The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 25 mg

    ATC: L01EX01

  • SUNITINIB MYLAN

    The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 37.5 mg

    ATC: L01EX01

  • SUNITINIB MYLAN

    The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 50 mg

    ATC: L01EX01

  • SUNITINIB ZENTIVA

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 12.5 mg

    ATC: L01EX01

  • SUNITINIB ZENTIVA

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 50 mg

    ATC: L01EX01

  • SUNITINIB ZENTIVA

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 37.5 mg

    ATC: L01EX01

  • SUNITINIB ZENTIVA

    The medicinal product is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib 25 mg

    ATC: L01EX01